View drug registration information details.
Items | Registration information |
ID | 2094 |
No | 2094 |
Brand Name | OMENIX 40 |
Ingredients | OMEPRAZOLE SODIUM BP 44.6323 MG EQ. TO OMEPRAZOLE 40 MG |
Dosage Form | POWDER FOR SOLUTION FOR INJECTION |
Primary Packaging | VIAL |
Storage | |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 1 VIAL + 1 AMPOULE OF 10 ML WATER FOR INJECTIONON |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | HEARTBURN, ANY SYMPTOMS OF GERD, EROSIVE ESOPHAGITIS, GASTRIC ULCER, DUODENAL ULCER AND REDUCTION OF RISK OF UPPER GI BLEEDING IN CRITICALLY ILL PATIENTS, PRIMARILY FOR THE TREATMENT OF ZOLLINGER-ELLISON SYNDROME |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | STERILE, FREEZE-DRIED, WHITE TO OFF-WHITE POROUS CAKE OR POWDER FILLED IN COLORLESS GLASS VIAL.
THE RECONSTITUTED SOLUTION IS CLEAR, COLORLESS AND HAVING NO VISIBLE RESIDUE AS UNDISSOLVED MATTER
|
Note | |
License Owner | PALAMY PHARMA CO., LTD |
Manufacturer | INCEPTA PHARMACEUTICALS LIMITED |
Country | BANGLADESH |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 05 I 3321/09 |
FDD Registration Date | 23-NOV-2023 |
Expiry Date | 22-Nov-2026 |
Back to drug list
|